MedPath

Philippines FDA Approvals

FDA Philippines approved pharmaceutical products and drug approvals

Food and Drug Administration of the Philippines
Philippines
30,876 Approvals
Showing 30281 to 30300 of 30,876 approvalsPage 1515 of 1544

CEFZIN

Issued: Mar 1, 2024

CEPRIME

Issued: Mar 1, 2024

Duodair

Issued: Mar 1, 2024

Stivarga

Issued: Mar 1, 2024

Sykoquit-25

Issued: Mar 1, 2024

BDIMI-C 250

Issued: Mar 1, 2024

Trimevita

Issued: Mar 1, 2024

AD Mycin

Issued: Mar 1, 2024

Hepravasc-5000

Issued: Mar 1, 2024

OMNIXIME

Issued: Mar 1, 2024

BDIMI-C 500

Issued: Mar 1, 2024

S-Celepra

Issued: Mar 1, 2024

Latosil

Issued: Mar 1, 2024

CTA-50

Issued: Mar 1, 2024

Ketozar

Issued: Mar 1, 2024

Doxyclene

Issued: Mar 1, 2024

Glipgludin

Issued: Mar 1, 2024

None

Issued: Mar 1, 2024

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.